AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations & Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.